STUDY RATIONALE AND CONTEXT
===========================

Traditionally, the most effective treatment for degenerative lumbar spinal stenosis is through surgical decompression [@JR02045-1]. Recently, interspinous devices have been used in lieu of standard laminectomy. The idea of using a device to distract the spinous processes for symptomatic relief is not new. It was first used in the 1950s but was abandoned secondary to device dislodgement, poor clinical indications, and implant malfunction. It is only recently that interspinous devices are being more popularized with various designs (from static spacers to dynamic devices) composed of an array of materials including allograft, titanium, polyetheretherketone, and elastomeric compounds. The mechanical mechanism by which interspinous devices are purported to treat spinal stenosis is to focally create slight spinal flexion by distraction of the spinous processes. This mimics the position of sitting, which increases the room for the nerves, potentially alleviating pain. Implantation of interspinous devices is a relatively straightforward surgical procedure and can be performed under local anesthesia. However, it is important to clearly identify evidence of whether interspinous devices are able to provide effective treatment and achieve similar goals to surgical decompression for degenerative lumbar spinal stenosis. In addition, the placement of interspinous devices is touted to be less morbid than a standard surgical decompression.

OBJECTIVES
==========

-   To compare the effectiveness of interspinous-device placement versus surgical decompression for the treatment of lumbar spinal stenosis.

-   To compare the morbidity of interspinous-device placement versus surgical decompression for the treatment of lumbar spinal stenosis.

MATERIALS AND METHODS
=====================

***Study design:*** Systematic review using a modified network analysis for indirect comparisons.

***Sampling:***

-   *Search:* PubMed, Cochrane collaboration database, and National Guideline Clearinghouse databases; bibliographies of key articles.

-   *Dates searched:* 1970 through March 2010.

***Inclusion criteria:*** Patients with lumbar spinal stenosis. Randomized controlled trials (RCTs) and nonrandomized comparison studies. RCTs only for indirect comparisons.

***Exclusion criteria:*** Trauma, significant lumbar instability, previous lumbar spine surgery, spondylolisthesis \> grade I and patient younger than 40 years. Comparison studies involving decompression surgery with simultaneous interspinous-device placement. Case series of interspinous-device placement or decompression surgery were not included because of the inability to calculate treatment effects without a comparison group.

***Outcomes:*** Disability, pain, function, and morbidity measures.

***Analysis:*** Changes in outcome scores from baseline to follow-up and complication rates were extracted for all studies. Treatment effects were calculated by comparing change scores between treatment groups. For the studies without a direct comparison between surgical decompression and interspinous-device placement, a modified network analysis for indirect treatment comparisons was made. The treatment effect was calculated by comparing the treatment effects of decompression versus conservative management to the treatment effects of interspinous-device placement to conservative management. Mean treatment effects between studies were compared. Complications were pooled; however, scores from functional measures were not pooled. Two independent reviewers assessed the strength of evidence using the GRADE criteria assessing quality, quantity, and consistency of results. Quality of evidence was downgraded for indirect comparisons and for small number of studies.

*Details about methods can be found in the electronic supplemental material at* []()

RESULTS
=======

We identified 97 citations and reviewed 85 abstracts. After abstract review, we excluded 72 studies that did not meet inclusion/exclusion criteria. We reviewed 13 full-text articles. Eight of these were excluded, leaving five studies meeting our inclusion criteria ([Fig 1](#FI02045-1){ref-type="fig"}). No RCTs or cohort studies making the direct comparison were identified; however, one study compared decompression with interspinous-device placement to decompression only [@JR02045-2] and one compared interspinous-device placement to decompression with instrumented fusion [@JR02045-3]; therefore, they were excluded. Three RCTs compared surgical decompression to conservative management and two RCTs compared interspinous-device placement to conservative management. These five studies were selected and used to perform indirect comparisons through a modified network analysis. All studies included subjects who had failed conservative management. Details of each study can be found in [Tables 1](#TB02045-1){ref-type="table"},[2](#TB02045-2){ref-type="table"}.

Description of included studies
-------------------------------

-   Treatment effects comparing decompression to conservative management were compared to the treatment effects comparing interspinous-device placement only to conservative management in different RCTs (modified network analysis).

-   RCT 1 compared surgical decompression only (n = 50) with nonoperative treatment consisting of nonsteroidal antiinflammatory drugs and physical therapy (n = 44) [@JR02045-4].

-   RCTs 2 and 3 (two studies) were combined as we used data from both studies which included 2- and 4-year follow-ups, respectively. Patients were either assigned to a surgical decompression-only group (n = 138) or to a nonoperative group consisting of physical therapy, nonsteroidal antiinflammatory drugs and epidural injections (n = 151) [@JR02045-1],[@JR02045-5]. These studies analyzed data with an intent-to-treat analysis and with an as-treated analysis separately. We summarized the intent-to-treat analysis because the RCT that it is compared to also analyzed data by intent to treat.

-   RCTs 4 and 5 (two studies) were combined as we used data from both studies that included 1- and 2-year follow-ups, respectively. Patients were either assigned to an interspinous-device placement group (n = 100) or to a nonoperative group consisting of physical therapy, nonsteroidal antiinflammatory drugs, analgesics, and at least one epidural steroid injection (n = 91) [@JR02045-6],[@JR02045-7].

Disability outcomes comparing interspinous devices to decompression
-------------------------------------------------------------------

The two treatments can be compared indirectly in the RCTs by Zucherman et al [@JR02045-6],[@JR02045-7] and Weinstein et al [@JR02045-1],[@JR02045-5] since they used the same outcomes measures (SF-36 Physical Function scores, respectively) ([Table 3](#TB02045-3){ref-type="table"}). The 12-month indirect treatment effect was 18.4 (20 versus 1.6) points using the SF-36 Physical Function score [@JR02045-1],[@JR02045-5],[@JR02045-6],[@JR02045-7] ([Fig 2](#FI02045-2){ref-type="fig"}).

Pain outcomes comparing interspinous-device placement to surgical decompression
-------------------------------------------------------------------------------

-   Differences in pain were observed through indirect comparisons. The RCTs by Weinstein et al [@JR02045-1],[@JR02045-5] and Zucherman et al [@JR02045-6],[@JR02045-7] measured change in SF-36 bodily pain scores at 12 months. The improvement in pain score was 23 and 31 points for the surgical decompression and interspinous groups, respectively ([Table 3](#TB02045-3){ref-type="table"}). When compared to the conservative groups, the treatment effects were 5.5 and 22 points, respectively. Therefore, the greater pain treatment effect (16.5 points) was observed in the interspinous group ([Fig 2](#FI02045-2){ref-type="fig"}).

-   Weinstein et al [@JR02045-1],[@JR02045-5] administered several other pain measures including a Low Back Pain Bothersome score, Leg Pain Bothersome score, and a Stenosis Bothersome score. When comparing the decompression to conservative management groups, the treatment effects were not statistically significant ([Table 2](#TB02045-2){ref-type="table"}).

Functional outcomes comparing interspinous-device place-ment to surgical decompression
--------------------------------------------------------------------------------------

-   The indirect treatment effects for improvement in walking distances comparing decompression (Malmivaara et al [@JR02045-4]) and interspinous (Zucherman et al [@JR02045-6],[@JR02045-7]) groups to conservative groups were 23% and 25%, respectively ([Table 3](#TB02045-3){ref-type="table"} and [Fig 2](#FI02045-2){ref-type="fig"}).

Safety outcomes comparing interspinous-device placement to surgical decompression
---------------------------------------------------------------------------------

-   The two RCTs by Malmivaara et al [@JR02045-4] and Weinstein et al [@JR02045-1],[@JR02045-5] reported 27% and 11.6% complication rates (perioperative and postoperative complications) in the surgical decompression groups compared to 0% in the conservative groups at 12 months, respectively. The RCT by Zucherman et al [@JR02045-6],[@JR02045-7] reported an 11% complication rate in the interspinous group compared to 0% in the conservative group.

-   The pooled complication rate for decompression was 15.2% and the complication rate for the interspinous device was 11% (χ^2^*P* = .33) ([Fig 2](#FI02045-2){ref-type="fig"}).

###### Demographics of studies for lumbar spinal stenosis (LSS) treated by decompression or interspinous device.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                                      Study design                                            Study\                                      Treatment description                                                                               Inclusion and exclusion criteria                                                     Follow-up time,\
                                                                                                         population                                                                                                                                                                                                                           % F/U
  ---------------------------------------------- ------------------------------------------------------- ------------------------------------------- --------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ --------------------------------
  **Malmivaara**\                                Randomized controlled trial\                            N = 94\                                     Decompression:\                                                                                     Inclusion:\                                                                          24 mo:\
  **et al (2007)**[@JR02045-4]                   December 1997--March 2001                               Decompression\                              Segmental decompression\                                                                            Clinical and x-ray symptomatic LSS\                                                  Decompression: 86%\
                                                                                                         n = 50\                                     Undercutting facetectomy\                                                                           Duration of symptoms \> 6 mo\                                                        Nonoperative: 91%\
                                                                                                         Age: 63 ± 9 y\                              Fusion if instability present or if a risk of instability\                                          Failed conservative treatment\                                                       12 mo:\
                                                                                                         Male: 22%\                                  Nonoperative:\                                                                                      Persistent pain without progressive neurological dysfunction\                        Decompression: 96%\
                                                                                                         Nonoperative treatment\                     Nonsteroidal antiinflammatory drugs\                                                                Exclusion:\                                                                          Nonoperative: 93%\
                                                                                                         n = 44\                                     Physical therapy consisting of body posture, trunk strengthening, stretching exercise, modalities   Severe LSS with intractable pain and progressive neurological dysfunction\           6 mo:\
                                                                                                         Age: 62 ± 9 y\                                                                                                                                  Mild LSS feeble enough to exclude surgery\                                           Decompression: 88%\
                                                                                                         Male: 45%                                                                                                                                       Stenosis not caused by degeneration\                                                 Nonoperative: 93%\
                                                                                                                                                                                                                                                         Spondylolytic spondylolisthesis\                                                     Available for all follow-ups:\
                                                                                                                                                                                                                                                         Previous lumbar spine surgery\                                                       Decompression: 86%\
                                                                                                                                                                                                                                                         Diagnosed lumbar herniated disc\                                                     Nonoperative: 84%
                                                                                                                                                                                                                                                         Other spinal disorders\                                                              
                                                                                                                                                                                                                                                         Severe osteoarthritis causing lower limb dysfunction                                 

  **Weinstein et al**\                           Randomized controlled trial intent-to-treat analysis\   N = 289\                                    Decompression:\                                                                                     Inclusion:\                                                                          48 mo:\
  **(2008 and 2010)**[@JR02045-1],[@JR02045-5]   March 2000-- March 2005                                 Age: 65.5 ± 10.5 y\                         Standard posterior decompression laminectomy\                                                       X-ray confirmation of LSS\                                                           Decompression: 67%\
                                                                                                         Male: 62%\                                  Nonoperative:\                                                                                      History of neurogenic claudication or radicular leg symptoms \>12 weeks\             Nonoperative: 64%\
                                                                                                         Assigned to decompression group\            Physical therapy\                                                                                   One or more levels\                                                                  24 mo:\
                                                                                                         n = 138\                                    Home exercise instruction\                                                                          All patients judged to be surgical candidates\                                       Decompression: 79%\
                                                                                                         Age: not reported (NR)\                     Epidural injections\                                                                                Exclusion:\                                                                          Nonoperative: 75%\
                                                                                                         Male: NR\                                   Chiropractic care\                                                                                  Lumbar instability\                                                                  12 mo:\
                                                                                                         Assigned to nonoperative treatment group\   Nonsteroidal antiinflammatory drugs\                                                                Patients with degenerative spondylolisthesis studied separately                      Decompression: 87%\
                                                                                                         n = 151\                                    Opioid analgesics                                                                                                                                                                        Nonoperative: 83%\
                                                                                                         Age: NR\                                                                                                                                                                                                                             6 mo:\
                                                                                                         Male: NR                                                                                                                                                                                                                             Decompression: 87%\
                                                                                                                                                                                                                                                                                                                                              Nonoperative: 89%

  **Zucherman et al**\                           Randomized controlled trial\                            N = 191\                                    Interspinous device:\                                                                               Inclusion:\                                                                          24 mo:\
  **(2004 and 2005)**[@JR02045-6],[@JR02045-7]   May 2000--July 2001                                     Age: 69.5 y\                                Mid-sagittal incision made over spinous processes of stenotic levels\                               X-ray confirmation of LSS\                                                           Interspinous device: 93%\
                                                                                                         Male: NR\                                   Hypertrophied facets that blocked entry to anterior interspinous space trimmed\                     Leg, buttock, or groin pain with or without back pain relieved during flexion\       Nonoperative: 89%\
                                                                                                         Interspinous device\                        X STOP interspinous device implanted at one or two levels\                                          ≥50 y\                                                                               12 mo:\
                                                                                                         n = 100\                                    Nonoperative:\                                                                                      One or two levels\                                                                   Interspinous device: 88%\
                                                                                                         Age: 70 y\                                  Physical therapy consisting of back school, stabilization exercises, massage and modalities\        Able to sit pain free for 50 min\                                                    Nonoperative: 75%\
                                                                                                         Male: 57%\                                  Received at least one epidural steroid injection\                                                   Walk \>50 feet\                                                                      6 mo:\
                                                                                                         Nonoperative treatment\                     Nonsteroidal antiinflammatories\                                                                    Completed 6 mo of nonoperative therapy\                                              Interspinous device: 88%\
                                                                                                         n = 91\                                     Analgesics\                                                                                         Exclusion:\                                                                          Nonoperative: 69%
                                                                                                         Age: 69 y\                                  Braces, such as abdominal binders and corsets, were permitted                                       Fixed motor deficit\                                                                 
                                                                                                         Male: 52%                                                                                                                                       Cauda equina syndrome\                                                               
                                                                                                                                                                                                                                                         Significant lumbar instability\                                                      
                                                                                                                                                                                                                                                         Previous lumbar surgery\                                                             
                                                                                                                                                                                                                                                         Significant peripheral neuropathy or acute denervation secondary to radiculopathy\   
                                                                                                                                                                                                                                                         Spondylolisthesis \> grade I\                                                        
                                                                                                                                                                                                                                                         Sustained pathological fractures\                                                    
                                                                                                                                                                                                                                                         Severe osteoporosis of vertebrae\                                                    
                                                                                                                                                                                                                                                         Active infection or systemic disease\                                                
                                                                                                                                                                                                                                                         Paget disease or metastasis of vertebrae                                             
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### Clinical outcomes and complications for lumbar spinal stenosis (LSS) treated by decompression or interspinous device.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source                                                         Clinical outcomes                                                               Other outcomes                                                                                                                                                                           
  -------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------- ---------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Malmivaara et al (2007)**[@JR02045-4]                        Oswestry Disability Index:\                                                     Oswestry Disability Index:\                                                    Oswestry Disability Index:\                                            Not reported                       Complications:\
                                                                 Decomp: --13.3 (34--20.7)\                                                      Decomp: --15.1 (34--19)\                                                       Decomp: --12.8 (34--21.2)\                                                                                8 perioperative complications including 7 lesions to dural sac corrected with sutures and 1 misplaced transpedicular screw replaced during original surgery\
                                                                 Nonop: --6.4 (34.7--28.3)\                                                      Nonop: --4.5 (34.7--30.2)\                                                     Nonop: --5.7 (34.7--29)\                                                                                  1 postoperative complication of respiratory distress due to pulmonary edema combined with stress ulcer\
                                                                 Treatment effect: --6.9\                                                        Treatment effect: --10.6\                                                      Treatment effect: --7.1\                                                                                  Revision/additional surgery:\
                                                                 (95% CI: 1.3--13.9)\                                                            (95% CI: 4.3--18.4)\                                                           (95% CI: 0.8--14.9)\                                                                                      4 (9%) patients in nonoperative group required surgery because of exacerbation of symptoms\
                                                                 Numeric Rating Scale for leg pain during walking:\                              Numeric Rating Scale for leg pain during walking:\                             Numeric Rating Scale for leg pain during walking:\                                                        3 (6%) further surgeries in decompression group; 1 as a result of misjudgment of stenotic level corrected same day; 1 due to peridural hematoma at 3 days; 1 patient had a new decompressive procedure at 12 mo
                                                                 Decomp: --4.01 (6.58--2.57)\                                                    Decomp: --3.85 (6.58-- 2.73)\                                                  Decomp: --3.54 (6.58-- 3.04)\                                                                             
                                                                 Nonop: --1.71 (6.3--4.59)\                                                      Nonop: --1.89 (6.3-- 4.41)\                                                    Nonop: --1.75 (6.3-- 4.55)\                                                                               
                                                                 Treatment effect: --2.30\                                                       Treatment effect: --1.96\                                                      Treatment effect: --1.79\                                                                                 
                                                                 (95% CI: 0.69--3.36)\                                                           (95% CI: 0.41--2.96)\                                                          (95% CI: 0.25--2.77)\                                                                                     
                                                                 Numeric Rating Scale for low back pain during walking:\                         Numeric Rating Scale for low back pain during walking:\                        Numeric Rating Scale for low back pain during walking:\                                                   
                                                                 Decomp: --4.09 (6.9--2.81)\                                                     Decomp: --4.18 (6.9--2.72)\                                                    Decomp: --4.16 (6.9--2.74)\                                                                               
                                                                 Nonop: --1.38 (6.83--5.45)\                                                     Nonop: --1.78 (6.83--5.05)\                                                    Nonop: --1.96 (6.83-- 4.87)\                                                                              
                                                                 Treatment effect: --2.71\                                                       Treatment effect: --2.40\                                                      Treatment effect: --2.20\                                                                                 
                                                                 (95% CI: 1.40--3.88)\                                                           (95% CI: 1.12--3.55)\                                                          (95% CI: 0.98--3.28)\                                                                                     
                                                                 Increase in walking distance, meters:\                                          Increase in walking distance, meters:\                                         Increase in walking distance, meters:\                                                                    
                                                                 Decomp: 1503 (1321--2824)\                                                      Decomp: 1721 (1321--3042)\                                                     Decomp: 1508 (1321--2829)\                                                                                
                                                                 Nonop: 1274 (1321--2638)\                                                       Nonop: 1460 (1364--2824)\                                                      Nonop: 1414 (1364--2778)\                                                                                 
                                                                 Treatment effect : 229\                                                         Treatment effect : 261\                                                        Treatment effect : 94\                                                                                    
                                                                 (95% CI: --1394--1022)                                                          Improvement: 130%\                                                             Improvement: 114%\                                                                                        
                                                                                                                                                 (95% CI: --1523--1087)                                                         (95% CI: --1338--1235)                                                                                    

  **Weinstein et al (2008 and 2010)**[@JR02045-1],[@JR02045-5]   Oswestry Disability Index:\                                                     Oswestry Disability Index:\                                                    Oswestry Disability Index:\                                            Oswestry Disability Index :\       Patient satisfaction, %:\
                                                                 Mean change\                                                                    Mean change\                                                                   Mean change\                                                           Mean change\                       Very or somewhat satisfied with symptoms\
                                                                 Decomp: --14.6 ± 1.9\                                                           Decomp: --14.9 ± 1.9\                                                          Decomp: --16.4 ± 1.9\                                                  Decomp: --12.2 ± 2.0\              Very or somewhat satisfied with care\
                                                                 Nonop: --13.7 ± 1.7\                                                            Nonop: --12.7 ± 1.8\                                                           Nonop: --12.9 ± 1.8\                                                   Nonop: --12.4 ± 1.9\               Self-rated major improvement in condition\
                                                                 Treatment effect: --0.9\                                                        Treatment effect: --2.2\                                                       Treatment effect: --3.5\                                               Treatment effect: 0.2\             6 mo:\
                                                                 (95% CI: --5.9-- 4.1)\                                                          (95% CI: --7.4--2.9)\                                                          (95% CI: --8.7--1.7)\                                                  (95% CI: 5.2--5.7)\                Decompression and nonoperative:\
                                                                 SF-36 Bodily pain:\                                                             SF-36 Bodily pain:\                                                            SF-36 Bodily pain:\                                                    SF-36 Bodily pain:\                1. 49.9 and 38.3 Treatment effect 11.7 (95% CI: --0.8--24.1)\
                                                                 Mean change\                                                                    Mean change\                                                                   Mean change\                                                           Mean change\                       2. 85.0 and 73.1Treatment effect 11.9 (95% CI: 1.9--21.9)\
                                                                 Decomp: 21.0 ± 2.2\                                                             Decomp: 23.0 ± 2.3\                                                            Decomp: 23.4 ± 2.3\                                                    Decomp: 15.9 ± 2.4\                3. 49.0 and 46.2Treatment effect 2.8 (95% CI: --10.0--15.5)\
                                                                 Nonop: 16.1 ± 2.1\                                                              Nonop: 17.5 ± 2.2\                                                             Nonop: 15.6 ± 2.2\                                                     Nonop: 15.7 ± 2.4\                 **12 mo:**\
                                                                 Treatment effect: 4.9\                                                          Treatment effect: 5.5\                                                         Treatment effect: 7.8\                                                 Treatment effect: 0.3\             Decompression and nonoperative:\
                                                                 (95% CI: --1.2--10.9)\                                                          (95% CI: --0.7--11.7)\                                                         (95% CI: 1.5--14.1)\                                                   (95% CI: --6.4--7.0)\              1. 53.4 and 40.7Treatment effect 12.8 (95% CI: --0.3--25.8)\
                                                                 SF-36 Physical function:\                                                       SF-36 Physical function:\                                                      SF-36 Physical function:\                                              SF-36 Physical function:\          2. 81.4 and 69.3Treatment effect 12.0 (95% CI: 0.8--23.2)\
                                                                 Mean change\                                                                    Mean change\                                                                   Mean change\                                                           Mean change\                       3. 55.3 and 44.2Treatment effect 11.1(95% CI: --2.1--24.2)\
                                                                 Decomp: 17.6 ± 2.3\                                                             Decomp: 18.0 ± 2.3\                                                            Decomp: 17.1 ± 2.4\                                                    Decomp: 12.7 ± 2.5\                **24 mo:**\
                                                                 Nonop:15.1 ± 2.2\                                                               Nonop: 16.4 ± 2.2\                                                             Nonop: 17.1 ± 2.3\                                                     Nonop: 15.9 ± 2.4\                 Decompression and nonoperative:\
                                                                 Treatment effect: 2.5\                                                          Treatment effect: 1.6\                                                         Treatment effect: 0.1\                                                 Treatment effect: --3.2\           1. 53.1 and 45.0 Treatment effect 8.1 (95% CI: --5.3--21.5)\
                                                                 (95% CI: --3.7-- 8.6)\                                                          (95% CI: --4.8--7.9)\                                                          (95% CI: --6.4--6.5)\                                                  (95% CI: --9.9--3.6)\              2. 76.2 and 68.5Treatment effect 7.6 (95% CI: --4.5--19.7)\
                                                                 Stenosis Bothersome Index:\                                                     Stenosis Bothersome Index:\                                                    Stenosis Bothersome Index:\                                            Stenosis Bothersome Index:\        3. 50.7 and 45.0Treatment effect 5.8(95% CI: --7.8--19.3)\
                                                                 NR\                                                                             Mean change\                                                                   Mean change\                                                           Mean change\                       Complications of the 166/171 patients (surgical information available) who had surgery regardless of assigned group:\
                                                                 Leg Pain Bothersome Index:\                                                     Decomp: --6.1 ± 0.7\                                                           Decomp: --6.3 ± 0.7\                                                   Decomp: --5.2 ± 0.75\              Surgery:\
                                                                 NR\                                                                             Nonop: --4.9 ± 0.7\                                                            Nonop: --5.6 ± 0.7\                                                    Nonop: --4.5 ± 0.73\               Decompression only (88%)\
                                                                 Low Back Pain Bothersome Index:\                                                Treatment effect: --1.2\                                                       Treatment effect: --0.7\                                               Treatment effect: --0.7\           Fusion (11%)\
                                                                 NR                                                                              (95% CI: --3.2-- 0.8)\                                                         (95% CI: --2.7--1.3)\                                                  (95% CI: --2.8--1.4)\              Death within 3 mo of surgery: 0%\
                                                                                                                                                 Leg Pain Bothersome Index:\                                                    Leg Pain Bothersome Index:\                                            Leg Pain Bothersome Index:\        Intraoperative complications:\
                                                                                                                                                 Mean change\                                                                   Mean change\                                                           Mean change\                       Dural tear/spinal fluid leak: 9%\
                                                                                                                                                 Decomp: --2.3 ± 0.2\                                                           Decomp: --2.2 ± 0.2\                                                   Decomp: --1.8 ± 0.2\               Postoperative complications:\
                                                                                                                                                 Nonop: --1.7 ± 0.2\                                                            Nonop: --1.8 ± 0.2\                                                    Nonop: --1.8 ± 0.2\                Wound hematoma: 2%\
                                                                                                                                                 Treatment effect: --0.6\                                                       Treatment effect: --0.3\                                               Treatment effect: 0\               Wound infection: 2%\
                                                                                                                                                 (95% CI: --1.3--0)\                                                            (95% CI: --1.0--0.3)\                                                  (95% CI: --0.7--0.6)\              Revision/additional surgery rate, %:\
                                                                                                                                                 Low Back Pain Bothersome Index:\                                               Low Back Pain Bothersome Index:\                                       Low Back Pain Bothersome Index:\   1-y rate: 4\
                                                                                                                                                 Mean change\                                                                   Mean change\                                                           Mean change\                       2-y rate: 7\
                                                                                                                                                 Decomp: --1.3 ± 0.2\                                                           Decomp: --1.3 ± 0.2\                                                   Decomp: --0.9 ± 0.2\               3-y rate: 10\
                                                                                                                                                 Nonop: --1.3 ± 0.2\                                                            Nonop: --1.6 ± 0.2\                                                    Nonop: --1.3 ± 0.2\                4-y rate: 13 (n = 22)\
                                                                                                                                                 Treatment effect: 0\                                                           Treatment effect: --0.3\                                               Treatment effect: 0.4\             Reason for additional surgery at 4 y (n = 22):\
                                                                                                                                                 (95% CI: --0.5--0.6)                                                           (95% CI: --0.2--0.9)                                                   (95% CI: --0.2--1.0)               Recurrent stenosis/progressive spondylolisthesis: 15 (9%)\
                                                                                                                                                                                                                                                                                                                                          Complication: 6 (4%)\
                                                                                                                                                                                                                                                                                                                                          New condition: 1 (0.60%)

  **Zucherman et al (2004 and 2005)**[@JR02045-6],[@JR02045-7]   Zurich Claudication Questionnaire\                                              SF-36\                                                                         Zurich Claudication Questionnaire\                                     NR                                 Surgical complications:\
                                                                 Overall success rates, %:\                                                      Mean change (Postoperative-preoperative)\                                      Mean % improvement in symptom severity domain score: (*P* \< .001)\                                       1 (1%) episode of respiratory distress within 72 hours\
                                                                 X STOP: 52\                                                                     Bodily pain:\                                                                  X STOP: baseline + 45.4%\                                                                                 1 (1%) ischemic coronary episode that resolved without clinical sequelae\
                                                                 Nonop: 9\                                                                       X STOP: 31 (56--25)\                                                           Nonop: baseline + 7.4%\                                                                                   1 (1%) patient with history of cardiovascular disease developed pulmonary edema\
                                                                 Symptom severity improvement rates, %:[\*](#FN02045-1){ref-type="table-fn"}\    Nonop: 9 (37--28)\                                                             Mean % improvement in physical function domain score: (*P* \< .001)\                                      1 (1%) wound dehiscence\
                                                                 X STOP: 75\                                                                     Treatment effect: 22\                                                          X STOP: baseline + 44.3%\                                                                                 1 (1%) swollen wound that was aspirated\
                                                                 Nonop: 39\                                                                      Physical function:\                                                            Nonop: baseline - 0.4%\                                                                                   1 (1%) hematoma\
                                                                 Physical function improvement rates, %:[\*](#FN02045-1){ref-type="table-fn"}\   X STOP: 30 (62--32)\                                                           Symptom severity improvement rates, % (*P* \< .001)\                                                      1 (1%) report of incisional pain\
                                                                 X STOP: 63\                                                                     Nonop: 10 (43--33)\                                                            X STOP: 60.2\                                                                                             1 (1%) patient fell and the implant dislodged posteriorly\
                                                                 Nonop: 18\                                                                      Treatment effect: 20\                                                          Nonop: 18.5\                                                                                              1 (1%) patient had an asymptomatic spinous-process fracture diagnosed on follow-up x-ray that healed without any recurrence of symptoms\
                                                                 Satisfaction rates, %:[\*](#FN02045-1){ref-type="table-fn"}\                    Role physical:\                                                                Physical function improvement rates, % (*P* \< .001)\                                                     1 (1%) patient reported worsening pain 382 days after treatment which was determined to possibly be related to the implant\
                                                                 X STOP: 65\                                                                     X STOP: 43 (57--14)\                                                           X STOP: 57\                                                                                               1 (1%) implant was placed posterior enough to be considered malpositioned\
                                                                 Nonop: 42                                                                       Nonop: 15 (32--17)\                                                            Nonop: 14.8\                                                                                              Revision/additional surgery:\
                                                                                                                                                 Treatment effect: 28\                                                          Satisfaction rates, % (*P* \< .001)\                                                                      During 24-mo F/U 24 (30%) of 81 patients in nonoperative group required decompressive surgery because of unresolved stenosis symptoms\
                                                                                                                                                 General health:\                                                               X STOP: 73.1\                                                                                             During 24-mo F/U 6 (6.4%) patients in X STOP group required decompressive surgery because of unresolved stenosis symptoms
                                                                                                                                                 X STOP: 3 (73--70)\                                                            Nonop: 35.9                                                                                               
                                                                                                                                                 Nonop: --6 (64-- 70)\                                                                                                                                                                    
                                                                                                                                                 Treatment effect: 9\                                                                                                                                                                     
                                                                                                                                                 Vitality:\                                                                                                                                                                               
                                                                                                                                                 X STOP: 6 (53--47)\                                                                                                                                                                      
                                                                                                                                                 Nonop: 30 (47--17)\                                                                                                                                                                      
                                                                                                                                                 Treatment effect: --24\                                                                                                                                                                  
                                                                                                                                                 Social function:\                                                                                                                                                                        
                                                                                                                                                 X STOP: 20 (79--59)\                                                                                                                                                                     
                                                                                                                                                 Nonop: 3 (67--64)\                                                                                                                                                                       
                                                                                                                                                 Treatment effect: 17\                                                                                                                                                                    
                                                                                                                                                 Role emotional:\                                                                                                                                                                         
                                                                                                                                                 X STOP: 25 (77--52)\                                                                                                                                                                     
                                                                                                                                                 Nonop: 9 (58--49)\                                                                                                                                                                       
                                                                                                                                                 Treatment effect: 16\                                                                                                                                                                    
                                                                                                                                                 Mental health:\                                                                                                                                                                          
                                                                                                                                                 X STOP: 2 (67--65)\                                                                                                                                                                      
                                                                                                                                                 Nonop: --1 (60--61)\                                                                                                                                                                     
                                                                                                                                                 Treatment effect: 3\                                                                                                                                                                     
                                                                                                                                                 Zurich Claudication Questionnaire\                                                                                                                                                       
                                                                                                                                                 Overall success rates, %\                                                                                                                                                                
                                                                                                                                                 X STOP: 59\                                                                                                                                                                              
                                                                                                                                                 Nonop: 12\                                                                                                                                                                               
                                                                                                                                                 Symptom severity improvement rates, %[\*](#FN02045-1){ref-type="table-fn"}\                                                                                                              
                                                                                                                                                 X STOP: 77\                                                                                                                                                                              
                                                                                                                                                 Nonop: 30\                                                                                                                                                                               
                                                                                                                                                 Symptom severity (no or mild pain), %:\                                                                                                                                                  
                                                                                                                                                 X STOP: 64\                                                                                                                                                                              
                                                                                                                                                 Nonop: 21\                                                                                                                                                                               
                                                                                                                                                 Physical function improvement rates, %[\*](#FN02045-1){ref-type="table-fn"}\                                                                                                             
                                                                                                                                                 X STOP: 71\                                                                                                                                                                              
                                                                                                                                                 Nonop: 23\                                                                                                                                                                               
                                                                                                                                                 Walking distance (patients able to walk 10 blocks), %\                                                                                                                                   
                                                                                                                                                 X STOP: 75 (\>2 blocks)\                                                                                                                                                                 
                                                                                                                                                 Nonop: 50 (\>2 blocks)\                                                                                                                                                                  
                                                                                                                                                 Satisfaction rates, %[\*](#FN02045-1){ref-type="table-fn"}\                                                                                                                              
                                                                                                                                                 X STOP: 71\                                                                                                                                                                              
                                                                                                                                                 Nonop: 50                                                                                                                                                                                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Absolute scores not given. Approximate mean change scores calculated from figures.

Decomp indicates decompression; nonop, nonoperative; NR, not reported; CI, confidence interval; F/U, follow-up; and numbers within parentheses are ranges unless otherwise indicated.

###### Changes from baseline to 12 and 24 months postoperatively and corresponding treatment effects for indirect comparisons of each surgical arm to a conservative arm.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                                                   Reference                                   Patients, N   Interspinous device   Decompression   Treatment effectA or B vs C                                         
  --------------------------------------------------------- ------------------------------------------- ------------- --------------------- --------------- ----------------------------- -------------- -------------- ------- -------
                                                                                                        Total         Rx arm(s)             12-mo change    24-mo change                  12-mo change   24-mo change   12 mo   24 mo

  **Disability**\                                           Weinstein et al [@JR02045-1],[@JR02045-5]   289           B (138)               ---             ---                           18.0           17.1           1.6     0.1
  SF-36 Physical Function                                                                                                                                                                                                       

  Zucherman et al [@JR02045-6],[@JR02045-7]                 191                                         A (100)       30                    NR              ---                           ---            20             NR      

  **Pain**\                                                 Weinstein et al [@JR02045-1],[@JR02045-5]   289           B (138)               ---             ---                           23.0           23.4           5.5     7.8
  SF-36 Bodily Pain                                                                                                                                                                                                             

  Zucherman et al [@JR02045-6],[@JR02045-7]                 191                                         A (100)       31                    NR              ---                           ---            22             NR      

  **Function**\                                             Malmivaara et al [@JR02045-4]               94            B (50)                ---             ---                           130%           114%           23%     10%
  Walking distance                                                                                                                                                                                                              

  Zucherman et al [@JR02045-6],[@JR02045-7]                 191                                         A (100)       75%                   NR              ---                           ---            25%            NR      

  **Safety**\                                               Malmivaara et al [@JR02045-4]               94            B (50)                ---             ---                           27%            NR             27%     NR
  Complication rates[\*](#FN02045-4){ref-type="table-fn"}                                                                                                                                                                       

  Weinstein et al [@JR02045-1],[@JR02045-5]                 289                                         B (138)       ---                   ---             11.6%                         NR             11.6%          0       

  Zucherman et al [@JR02045-6],[@JR02045-7]                 191                                         A (100)       11%                   NR              ---                           ---            11%            0       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Dashes represent treatment arms that were not included in the particular study. NR indicates not reported; Rx, treatment arms (A, interspinous device; B, decompression; C, conservative); and N, all subjects in study. Change in points at 12 months and 24 months if no units are listed; change is given in percentage. The lower the score, the higher the function.

Treatment effect indicates difference between interspinous (A) or decompression (B) versus conservative (C) arm change scores.

All postoperative complications, except additional surgery.

###### Comparing 12- and 24-month mean percentage improvements in Zurich Claudication subscale scores and treatment effects between interspinous device and conservative management in the study by Zuchermanet al .

  Improvement            Interspinous   Conservative   Treatment effect                           
  ---------------------- -------------- -------------- ------------------ ----------- ----------- -----------
                         12 months      24 months      12 months          24 months   12 months   24 months
  Physical function, %   71             57             23                 14.8        48          42.2
  Symptom severity, %    77             60.2           30                 18.5        47          47.2

###### Comparing 12- and 24-month improvements in the mean Oswestry Disability Index (ODI) scores and treatment effects between decompression and conservative management in the studies by Malmivaara et al and Weinstein et al , respectively.

  Score          Decompression   Conservative   Treatment effect                           
  -------------- --------------- -------------- ------------------ ----------- ----------- -----------
                 12 months       24 months      12 months          24 months   12 months   24 months
  ODI (points)   −15.1           −12.8          −4.5               −5.7        −10.6       −7.1
  ODI (points)   −14.9           −16.4          −12.7              −12.9       −2.2        −3.5

Negative scores represent improvement in function.

![Results of literature search.](ebsj02045-1){#FI02045-1}

![Indirect treatment effects (TE)^\*^ comparing surgical decompression to interspinous-device placement.](ebsj02045-2){#FI02045-2}

EVIDENCE SUMMARY
================

  Outcomes         Strength of evidence[\*](#FN02045-6){ref-type="table-fn"}   Conclusions/Comments
  ---------------- ----------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Disability   low                                                         Indirect treatment effect favored the interspinous device compared to decompression 12 months after surgery using the SF-36 Physical Function score.
  2\. Pain         low                                                         Indirect treatment effect favored the interspinous device compared to decompression 12 months after surgery using the SF-36 Bodily Pain score.
  3\. Function     low                                                         No significant indirect treatment effect for walking distance at 12 months comparing the two treatments.
  4\. Safety       low                                                         No significant differences in the complication rates between the interspinous device (11%) and decompression (15.2%).

Low evidence indicates further research is likely to have an important impact on the confidence in the estimate of effect and is likely to change the estimate.

DISCUSSION
==========

There was low evidence supporting greater treatment effects for interspinous-device placement compared to decompression for disability and pain outcomes at 12 months. There was low evidence demonstrating little to no difference in treatment effects between groups for walking distance and complication rates. GRADE criteria suggest that low evidence indicates "further research is very likely to have an important impact on the confidence in the estimate of effect and is likely to change the estimate."

The observations that are seen in this modified network analysis must be taken within the context that no direct comparisons between interspinous spacers and decompressive laminectomy exist. Thus, the network analysis model analyzes best available evidence from the two different treatment studies for an indirect comparison.

This indirect comparison must be carefully analyzed because of the inherent possibilities of different treatment groups (ie, heterogeneity).

The first caveat is the intent-to-treat analysis as opposed to an as-treated analysis. In the Weinstein et al study [@JR02045-1],[@JR02045-5] , 43% of the patients who were in the nonsurgical arm crossed over to having surgery at the 2-year mark. In addition, only 67% of the surgical arm had actually undergone surgery. In the article, the authors\' state, " ... the intention-to-treat analysis underestimates the true effect of surgery." They go on to conclude, "In the as-treated analysis ... those treated surgically showed significantly greater improvement ... " Further, none of the patients in Zucherman et al [@JR02045-6],[@JR02045-7] crossed over. Thus, because of the cross over in the Weinstein et al study [@JR02045-1],[@JR02045-5], the treatment effect may not be as great as that seen in the Zucherman et al study ([Tables 4](#TB02045-4){ref-type="table"},[5](#TB02045-5){ref-type="table"}) [@JR02045-6],[@JR02045-7].

Another point to consider is the difference in the enrollment of patients. Weinstein et al [@JR02045-1],[@JR02045-5] and Malmivaara et al [@JR02045-4] enrolled patients who were diagnosed with lumbar stenosis who failed conservative therapy. Zucherman et al [@JR02045-6],[@JR02045-7], however, enrolled patients who had pain relief while sitting. Thus, the patients enrolled in that study were known to have alleviation of pain with their lumbar spines in flexion. This may have created a selection bias in that this study only enrolled patients who would respond favorably to an interspinous device.

Morbidity was calculated from the complication rates, both perioperatively and postoperatively. Note that both lumbar decompressive surgery groups (Weinstein et al [@JR02045-1],[@JR02045-5] and Malmivaara et al [@JR02045-4]) had patients with instrumented fusion (a more morbid procedure than decompression alone). This would have skewed the complication rate higher for the surgical decompression groups, since these were not simple decompressive procedures.

The indirect treatment effect for disability and pain favors the interspinous device compared to decompression. No significant treatment effect differences were observed for postoperative-walking distance improvement or complication rates; however, findings should be considered with caution due to indirect comparisons and short follow-up periods.

Given the limitations of our network analysis, we nonetheless evaluated the best evidence currently available ([Table 6](#TB02045-6){ref-type="table"}). Eventually, studies with direct comparisons evaluating the efficacy between interspinous devices and surgical decompression will hopefully give a more precise answer.

EDITORIAL STAFF PERSPECTIVE
---------------------------

There are several noteworthy factors regarding this topic and the systematic review as performed:

-   The current strength of evidence favoring interspinous spacers compared to decompression surgery with or without fusion regarding factors of disability and pain is low, meaning that "Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate."

-   There was general surprise voiced that there is no direct comparison study between decompression surgery alone (in properly selected patients) and interspinous spacers without decompression. For various reasons the higher-grade evidence relies on comparisons, such as interspinous spacers versus nonoperative modalities, decompression and fusion versus decompression and surgical decompression versus nonoperative treatment. The absence of the most compelling form of comparison studies---decompression alone versus interspinous spacer for more stable forms of stenosis and decompression and fusion versus decompression and interspinous spacer for more unstable forms of stenosis---was quoted as being "lamentable" and "overdue for correction."

-   The absence of clinically relevant direct comparison studies necessitated a 'network analysis' with its inherent shortcomings of error through heterogeneity of its study cohorts and lower level of familiarity to a clinician community.

-   The short-term follow-up of studies with interspinous spacers (12 months) was noted to likely underreport complications, such as device loosening and need for more complex revision surgery for patients with interspinous devices, which would appear to be more likely to fail with time.

-   The impact of patients\' complications with interspinous devices as expressed in invasiveness of potential corrective surgery compared to less expensive and simple decompression surgery is presently not understood.

-   The potential for financial conflict of interest affecting several authors related to the development and subsequent marketing of certain interspinous devices was pointed out. To date there are no prospective comparison studies from financially disinterested third-party groups.

***Case example***

(Case provided by Jens Chapman)

Two years after L3/4 interspinous process-spacer placement a physically very active and healthy 65-year-old man presented with severe bilateral leg pain brought on by short-distance walking and relieved by bending and squatting ([Fig 3a](#FI02045-3a){ref-type="fig"}). At the time the procedure had brought substantial symptom relief, however progressive symptom recurrence was noted about 18 months after the index procedure. The patient was found to have an X-Stop device at his L3/4 interspace with heterotopic bone formation surrounding the implant, as well as a subtle grade 1 degenerative spondylolisthesis.

The MRI scan revealed persistent significant central stenosis with facet hypertrophy and lateral recess compromise ([Fig 3d](#FI02045-3d){ref-type="fig"}).

Because of failure of nonoperative treatment the patient underwent removal of the device and simple midline-sparing hemilaminotomies with partial facetectomies through a keyhole laminotomy approach ([Fig 3e](#FI02045-3e){ref-type="fig"}). Abundant heterotopic bone surrounding the implant was carefully removed, while avoiding injury to the ligaments. Since decompressive surgery the patient experienced complete relief of lower extremity and back symptoms and return to activities of daily living including competitive golf 6 months to date.

This case illustrates some concerns about interspinous spacers. The role of simple soft-tissue--sparing decompression surgery, while avoiding destabilizing measures, compared to an implant-based nonfusion procedure remains to be established and cannot be concluded based on the current state of the literature. Does a nonfusion device in fact set up patients for more revision surgeries in the intermediate and longer run compared to simple decompression or fusion surgery in appropriately selected patient? Another question worth debating is how long does a satisfactory result in elective spine surgery have to last to be counted as a success? Alternatively, when is a revision procedure performed at an index level a complication? This case certainly illustrates some of the many unanswered questions.

![Preoperative x-ray (AP view).](ebsj02045-3a){#FI02045-3a}

![Preoperative x-ray (extension).](ebsj02045-3b){#FI02045-3b}

![Preoperative x-ray (flexion).](ebsj02045-3c){#FI02045-3c}

![Magnetic resonance imaging (axial).](ebsj02045-3d){#FI02045-3d}

![The intraoperative site revealed extensive foreign body debris (dark spots) and abundant reactive connective tissue build up around the area of the interspinous spacers.](ebsj02045-3e){#FI02045-3e}
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